|
Volumn 41, Issue 3, 2003, Pages 237-246
|
Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
FIBRINOGEN;
SPIRAMYCIN;
ADULT;
AGED;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HEART INFARCTION;
HUMAN;
IMMUNOLOGY;
INCIDENCE;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGINA, UNSTABLE;
ANTI-BACTERIAL AGENTS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
FEMALE;
FIBRINOGEN;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
SPIRAMYCIN;
TREATMENT OUTCOME;
|
EID: 16544365345
PISSN: 12204749
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|